Is used to stabilize the spinal vertebrae. This definition is adapted from www.spine-health.com. It is estimated that the orthobiology market for spinal fusion is growing to $2.2 billion in 2030,.
Kuros Biosciences AG: Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.
Kuros Biosciences AG / Key word(s): Study resultsKuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial 13.07.2023 / 19:29 CET/CEST First investigational trial of drug-biologic bone graft for spinal fusion 50 patients have been enrolled in the Phase 2 trial Potential to address $2.2B ma.